| abstract |
Disclosed is a drug useful for improving postprandial hypotension or preventing a disease or condition that can be induced by postprandial hypotension. A blood pressure lowering (for example, postprandial hypotension) that occurs after eating in a subject having normal blood glucose level, a patient with a disease such as a neurological disease or heart disease, or an elderly person or a healthy person, including an α-glucosidase inhibitor. A preventive agent for a disease or condition (for example, dizziness, syncope, myocardial infarction, cerebral infarction) induced by postprandial hypotension, comprising an ameliorating agent and an α-glucosidase inhibitor. [Selection figure] None |